Investments to Support Access to Drugs for Rare Diseases

On March 22, 2023 the Government announced a total investment of up to $1.5 billion over three years in support of the first-ever National Strategy for Drugs for Rare Diseases to help increase access to, and affordability of, promising and effective drugs...
2022 Recipient of the Lupus Canada Catalyst Award

2022 Recipient of the Lupus Canada Catalyst Award

Researcher Éric Boilard, PhD Research Proposal Abstract  Platelets are tiny cell fragments in blood circulation in charge of the prevention of bleedings. However, in systemic lupus erythematosus (lupus), our studies and that of others demonstrate that platelets can...